News from us and our partners

Tags

Topics

0 results

News
16 May, 2022
Papiernik tells Bloomberg that biotech is essential to pharma industry
News
16 May, 2022
Corriere della Serra interviews Graziano Seghezzi after Sofinnova Partners signs deal with Apollo
News
16 May, 2022
Antoine Papiernik tells Le Figaro that Apollo deal will help Sofinnova finance the next generation of game-changing health care start-ups
News
16 May, 2022
Sofinnova Partners and Apollo form strategic partnership in life sciences
News
12 May, 2022
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
News
10 May, 2022
NodThera announces clinical progress for lead NLRP3 inflammasome inhibitors and candidate selection of novel brain-penetrant compound
News
5 May, 2022
GFBiochemicals raises €15m series A to advance its mission to end chemical pollution
News
4 May, 2022
Asceneuron awarded second grant from The Michael J. Fox Foundation for accelerated research into novel Parkinson’s disease therapies
News
4 May, 2022
Enthera Pharmaceuticals appoints Aled Williams as Chief Executive Officer
News
3 May, 2022
GlycoEra AG appoints Ganesh V. Kaundinya as President and Chief Executive Officer
News
3 May, 2022
RefleXion announces real-world evidence outcomes registry to evaluate treatment impact on all stages of cancer
News
3 May, 2022
Biotalys wins new FRAC resistance class for Evoca biofungicide
News
2 May, 2022
Catamaran Bio to present preclinical data at ASGCT Annual Meeting to support CAR-NK approach for solid tumors
News
27 April, 2022
Catamaran Bio appoints Cherry Thomas, MD, as Chief Medical Officer
News
20 April, 2022
Sofinnova Partners announces new investment in Nephris, an innovative biotech targeting chronic kidney diseases
News
12 April, 2022
Sitryx Therapeutics strengthens leadership team with appointment of Ravi M. Rao as Chief Medical Officer

Papiernik tells Bloomberg that biotech is essential to pharma industry

Corriere della Serra interviews Graziano Seghezzi after Sofinnova Partners signs deal with Apollo

Antoine Papiernik tells Le Figaro that Apollo deal will help Sofinnova finance the next generation of game-changing health care start-ups

Sofinnova Partners and Apollo form strategic partnership in life sciences

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform

NodThera announces clinical progress for lead NLRP3 inflammasome inhibitors and candidate selection of novel brain-penetrant compound

GFBiochemicals raises €15m series A to advance its mission to end chemical pollution

Asceneuron awarded second grant from The Michael J. Fox Foundation for accelerated research into novel Parkinson’s disease therapies

Enthera Pharmaceuticals appoints Aled Williams as Chief Executive Officer

GlycoEra AG appoints Ganesh V. Kaundinya as President and Chief Executive Officer

RefleXion announces real-world evidence outcomes registry to evaluate treatment impact on all stages of cancer

Biotalys wins new FRAC resistance class for Evoca biofungicide

Catamaran Bio to present preclinical data at ASGCT Annual Meeting to support CAR-NK approach for solid tumors

Catamaran Bio appoints Cherry Thomas, MD, as Chief Medical Officer

Sofinnova Partners announces new investment in Nephris, an innovative biotech targeting chronic kidney diseases

Sitryx Therapeutics strengthens leadership team with appointment of Ravi M. Rao as Chief Medical Officer